Research Application and Potential Benefits of BPC-157 BPC-157 has been studied for its potential benefits in various tissue and healing models
Copper in excess is genuinely toxic, and in a zebrafish model free copper caused heart toxicity (Hsiao et al., 2020) though in that same study the GHK peptide chelated copper and reduced the harm, so GHK-Cu is not equivalent to free copper
SLU-PP-332 Clinical Evidence Context Human evidence: none
The warnings, dated December 10, were issued to Prime Peptides, Summit Research Peptides, Swisschems and Xcel Research, all of which were found to be selling unapproved GLP-1 treatments that, despite being labelled as for research purposes, were marketed for human use
Disclaimer: This article is intended for B2B informational purposes for research institutions, compounding pharmacy professionals, and peptide manufacturers
Life Sci, 88 (11-12) (2011), pp